{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:18:21Z","timestamp":1783394301224,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic and Legal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jflm.2026.103187","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:38:36Z","timestamp":1780760316000},"page":"103187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Technical note: Identification of the novel benzodiazepine 3-hydroxy desalkylgidazepam within PSNI tablet seizures in Northern Ireland"],"prefix":"10.1016","volume":"121","author":[{"given":"Maurice Robert","family":"Jeffers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Robert","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jflm.2026.103187_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2025.112708","article-title":"Designer benzodiazepines: availability, motives, and fatalities. A systematic narrative review of human studies","volume":"272","author":"Van Amsterdam","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.jflm.2026.103187_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.janxdis.2011.01.002","article-title":"The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs","volume":"25","author":"L\u00f3pez-Mu\u00f1oz","year":"2011","journal-title":"J Anxiety Disord"},{"issue":"2","key":"10.1016\/j.jflm.2026.103187_bib3","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system\u2013mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"issue":"1","key":"10.1016\/j.jflm.2026.103187_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"Dell'Osso","year":"2013","journal-title":"Eur Psychiatry"},{"issue":"9","key":"10.1016\/j.jflm.2026.103187_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","article-title":"The history of benzodiazepines","volume":"28","author":"Wick","year":"2013","journal-title":"Consult Pharm"},{"issue":"6","key":"10.1016\/j.jflm.2026.103187_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ph14060560","article-title":"Designer benzodiazepines: a review of toxicology and public health risks","volume":"14","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jflm.2026.103187_bib7","series-title":"New Benzodiazepines in Europe - A Review","year":"2021"},{"issue":"1","key":"10.1016\/j.jflm.2026.103187_bib8","first-page":"37","article-title":"The emergence of new Psychoactive Substance (NPS) benzodiazepines: a review drug Test anal","volume":"10","author":"Manchester","year":"2018"},{"key":"10.1016\/j.jflm.2026.103187_bib9","series-title":"Recently Encountered Uncontrolled Novel Benzodiazepines and Related Compounds: Update 2024","year":"2024"},{"key":"10.1016\/j.jflm.2026.103187_bib10","series-title":"Misuse of Drugs Act 1971 (Amendment) Order 2017","year":"2017"},{"key":"10.1016\/j.jflm.2026.103187_bib11","series-title":"Misuse of Drugs Act 1971 (Amendment) Order 2021","year":"2021"},{"issue":"3","key":"10.1016\/j.jflm.2026.103187_bib12","first-page":"45","article-title":"[The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level]","volume":"101","author":"Neznamov","year":"2001","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"4","key":"10.1016\/j.jflm.2026.103187_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/jat\/bkad004","article-title":"Designer benzodiazepines gidazepam and desalkylgidazepam (bromonordiazepam): what do we know?","volume":"47","author":"Maskell","year":"2023","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.jflm.2026.103187_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-025-01153-8","article-title":"A qualitative study of benzodiazepine\/z-drug and opioid co-use patterns and overdose risk","volume":"22","author":"Family","year":"2025","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.jflm.2026.103187_bib15","series-title":"RADAR Alert: New Benzodiazepines: Public Health Scotland","year":"2026"},{"key":"10.1016\/j.jflm.2026.103187_bib16","series-title":"A Review of the Evidence on the Use and Harms of 2-benzyl Benzimidazole (\u2018Nitazenes\u2019) and Piperidine Benzimidazolone (\u2018brorphine-like\u2019) Opioids","year":"2022"},{"key":"10.1016\/j.jflm.2026.103187_bib17","article-title":"Everything you need to know about nitazenes","author":"Wilkinson","year":"2024","journal-title":"Pharm J[Internet]"}],"updated-by":[{"DOI":"10.1016\/j.jflm.2026.103199","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Journal of Forensic and Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X26001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X26001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:12:32Z","timestamp":1783393952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1752928X26001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":17,"alternative-id":["S1752928X26001198"],"URL":"https:\/\/doi.org\/10.1016\/j.jflm.2026.103187","relation":{},"ISSN":["1752-928X"],"issn-type":[{"value":"1752-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technical note: Identification of the novel benzodiazepine 3-hydroxy desalkylgidazepam within PSNI tablet seizures in Northern Ireland","name":"articletitle","label":"Article Title"},{"value":"Journal of Forensic and Legal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jflm.2026.103187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103187"}}